|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | Quinoline-Val-Asp-Difluorophenoxymethylketone | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||||||||||
| 化学式 | C26H25F2N3O6
|
||||||||||||||
| 分子量 | 513.49 | CAS No. | 1135695-98-5 | ||||||||||||
| Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (194.74 mM) | ||||||||||||
| Ethanol | 100 mg/mL (194.74 mM) | ||||||||||||||
| Water | Insoluble | ||||||||||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||||||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||||||||||
| 製品説明 | Q-VD-Oph (Quinoline-Val-Asp-Difluorophenoxymethylketone) is a potent pan-caspase inhibitor with IC50 ranged from 25 to 400 nM for caspases 1,3,8, and 9. Q-VD-OPh can inhibits HIV infection. |
|---|---|
| in vitro | Q-VD-OPh (5-100 μM) potently inhibits Actinomycin D-induced DNA laddering and subsequent apoptosis with minimal toxicity in WEHI 231 cells. Q-VD-OPh prevents caspase mediated cleavage of PARP and activation of the major initiator and effector caspases. [2] Q-VD-OPh protects cardiac myocytes from virus-induced apoptosis in vitro. [4] |
| in vivo | Q-VD-OPh inhibits caspase-1 activity, IL-18 protein expression, and neutrophil infiltration during ischemic ARF in mice. [3] In vivo, caspase inhibition by Q-VD-OPh provides protection from virus-induced myocardial injury, with a significant reduction in caspase-3 activity. [4] In TgCRND8 mice, Q-VD-OPh inhibits caspase-7 activation and limits the pathological changes associated with tau, including caspase cleavage. [5] |
| 細胞アッセイ | 細胞株 | WEHI-231 cells |
|---|---|---|
| 濃度 | ~1000 μM | |
| 反応時間 | 4 hours | |
| 実験の流れ | Caspase inhibitors are added at the indicated concentrations 30 minutes prior to the addition of apoptotic stimuli. Viability and cell number are determined by trypan blue exclusion from three random fields of greater than 200 cells/field. All experiments are performed a minimum of three times. | |
| 動物実験 | 動物モデル | C57BL/6 mice |
| 投薬量 | ~120 mg/kg | |
| 投与方法 | Intraperitoneal administration |
|

Data from [Data independently produced by , , Mol Nutr Food Res, 2017, 61(12)]

Data from [Data independently produced by , , Neurochem Res, 2018, 43(6):1200-1209]
| Enhanced regenerative and developmental potential of embryonal and stem cell-derived platelets compared to adult platelets [ Cell Rep Med, 2025, 6(8):102297] | PubMed: 40795844 |
| Ironomycin induces mantle cell lymphoma cell death by targeting iron metabolism addiction [ Theranostics, 2025, 15(7):2834-2851] | PubMed: 40083931 |
| Interplay of ferroptotic and apoptotic cell death and its modulation by BH3-mimetics [ Cell Death Differ, 2025, 10.1038/s41418-025-01514-7] | PubMed: 40301648 |
| A nonenzymatic dependency on inositol-requiring enzyme 1 controls cancer cell cycle progression and tumor growth [ PLoS Biol, 2025, 23(4):e3003086] | PubMed: 40208872 |
| Interferon regulatory factor 4 mediates nonenzymatic IRE1 dependency in multiple myeloma cells [ PLoS Biol, 2025, 23(4):e3003096] | PubMed: 40215234 |
| The reaction mechanism for glycolysis side product degradation by Parkinson's disease-linked DJ-1 [ J Cell Biol, 2025, 224(8)e202411078] | PubMed: 40464736 |
| NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption [ Commun Biol, 2025, 8(1):236] | PubMed: 39953264 |
| The Polybrominated Diphenyl Ether Bromoxib Disrupts Nuclear Import and Export by Affecting Nucleoporins of the Nuclear Pore Complex [ Mar Drugs, 2025, 23(3)108] | PubMed: 40137294 |
| The PP2A-B55α phosphatase is a master regulator of mitochondrial degradation and biogenesis [ Sci Adv, 2025, 11(40):eadw7376] | PubMed: 41042873 |
| TBK1 and IKKε prevent premature cell death by limiting the activity of both RIPK1 and NLRP3 death pathways [ Sci Adv, 2025, 11(10):eadq1047] | PubMed: 40053580 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。